BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 24176612)

  • 1. A prospective study of methylnaltrexone for opioid-induced constipation in advanced illness: should we use it or not?
    Centeno C; Carranza O; Zuriarrain Y; Portela MA; Larumbe A; Canal J; Palomar C
    J Pain Symptom Manage; 2013 Nov; 46(5):e1-3. PubMed ID: 24176612
    [No Abstract]   [Full Text] [Related]  

  • 2. Methylnaltrexone for opioid-induced constipation in advanced illness.
    Sanz Rubiales A; del Valle Rivero ML
    N Engl J Med; 2008 Sep; 359(10):1070-1; author reply 1071. PubMed ID: 18768955
    [No Abstract]   [Full Text] [Related]  

  • 3. Methylnaltrexone in palliative care: further research is needed.
    Clark K; Currow DC
    J Pain Symptom Manage; 2014 Feb; 47(2):e5-6. PubMed ID: 24411184
    [No Abstract]   [Full Text] [Related]  

  • 4. Methylnaltrexone for opioid-induced constipation in advanced illness.
    Chappell D; Rehm M; Conzen P
    N Engl J Med; 2008 Sep; 359(10):1071; author reply 1071. PubMed ID: 18777614
    [No Abstract]   [Full Text] [Related]  

  • 5. Methylnaltrexone for the Treatment of Constipation in Critically Ill Children.
    López J; Fernández SN; Santiago MJ; Urbano J; González R; Fernández-Llamazares C; López-Herce J
    J Clin Gastroenterol; 2016 Apr; 50(4):351-2. PubMed ID: 26950234
    [No Abstract]   [Full Text] [Related]  

  • 6. Subsidised use of methylnaltrexone in Australia for palliative care.
    Rowett DS; Clark K; Robinson MK; Currow DC
    Med J Aust; 2012 Nov; 197(9):492. PubMed ID: 23121581
    [No Abstract]   [Full Text] [Related]  

  • 7. Methylnaltrexone for opioid-induced constipation in advanced illness.
    Thomas J; Karver S; Cooney GA; Chamberlain BH; Watt CK; Slatkin NE; Stambler N; Kremer AB; Israel RJ
    N Engl J Med; 2008 May; 358(22):2332-43. PubMed ID: 18509120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylnaltrexone treatment of opioid-induced constipation in patients with advanced illness.
    Chamberlain BH; Cross K; Winston JL; Thomas J; Wang W; Su C; Israel RJ
    J Pain Symptom Manage; 2009 Nov; 38(5):683-90. PubMed ID: 19713070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylnaltrexone: a subcutaneous treatment for opioid-induced constipation in palliative care patients.
    Kyle G
    Int J Palliat Nurs; 2009 Nov; 15(11):533-40. PubMed ID: 20081727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioid side effects--mechanism-based therapy.
    Berde C; Nurko S
    N Engl J Med; 2008 May; 358(22):2400-2. PubMed ID: 18509126
    [No Abstract]   [Full Text] [Related]  

  • 11. Methylnaltrexone: a novel approach for the management of opioid-induced constipation in patients with advanced illness.
    Diego L; Atayee R; Helmons P; von Gunten CF
    Expert Rev Gastroenterol Hepatol; 2009 Oct; 3(5):473-85. PubMed ID: 19817669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylnaltrexone bromide: new drug for the treatment of opioid-induced bowel dysfunction.
    Baker DE
    Rev Gastroenterol Disord; 2009; 9(3):E84-93. PubMed ID: 19898269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of constipation in patients receiving palliative care.
    Cayley WE
    Am Fam Physician; 2011 Dec; 84(11):1227-8. PubMed ID: 22150655
    [No Abstract]   [Full Text] [Related]  

  • 14. Methylnaltrexone bromide for the treatment of opioid-induced constipation in patients with advanced illness--a cost-effectiveness analysis.
    Earnshaw SR; Klok RM; Iyer S; McDade C
    Aliment Pharmacol Ther; 2010 Apr; 31(8):911-21. PubMed ID: 20096019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal treatment of opioid induced constipation in daily clinical practice - an observational study.
    Neefjes ECW; van der Wijngaart H; van der Vorst MJDL; Ten Oever D; van der Vliet HJ; Beeker A; Rhodius CA; van den Berg HP; Berkhof J; Verheul HMW
    BMC Palliat Care; 2019 Mar; 18(1):31. PubMed ID: 30922276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylnaltrexone: treatment for opioid-induced constipation.
    Licup N; Baumrucker SJ
    Am J Hosp Palliat Care; 2011 Feb; 28(1):59-61. PubMed ID: 20801917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylnaltrexone: treatment for opioid-induced constipation--not convinced yet.
    HaiNan Liu ; Xiulu Ruan
    Am J Hosp Palliat Care; 2011 Jun; 28(4):290; author reply 291. PubMed ID: 21454318
    [No Abstract]   [Full Text] [Related]  

  • 18. The role of methylnaltrexone in opioid-induced constipation.
    Hellwig TR; Pottebaum AA
    S D Med; 2013 Oct; 66(10):425, 427. PubMed ID: 24244983
    [No Abstract]   [Full Text] [Related]  

  • 19. An overview of constipation and newer therapies.
    Enck RE
    Am J Hosp Palliat Care; 2009; 26(3):157-8. PubMed ID: 19531698
    [No Abstract]   [Full Text] [Related]  

  • 20. Methylnaltrexone reverses opioid-induced constipation.
    Stephenson J
    Lancet Oncol; 2002 Apr; 3(4):202. PubMed ID: 12067677
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.